Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Hysteroscopic sterilization

James Greenberg, MD
Amanda C Yunker, DO, MSCR
Section Editors
Jody Steinauer, MD, MAS
Howard T Sharp, MD
Deputy Editor
Sandy J Falk, MD, FACOG


Female surgical sterilization is the second most commonly used method of contraception among women in the United States. Between 2006 and 2010, of those women who used some type of contraception, 27 percent chose female sterilization, 28 percent chose an oral form of contraception, and 16 percent reported using condoms [1].

For women who no longer desire fertility, sterilization is a safe and highly effective option. Hysteroscopic sterilization can be performed in an outpatient setting and is the least invasive approach to female sterilization.

Hysteroscopic sterilization will be reviewed here. An overview of general principles of female sterilization, as well as postpartum and laparoscopic sterilization and general issues related to hysteroscopy, are discussed separately. (See "Overview of female sterilization" and "Postpartum sterilization" and "Laparoscopic female sterilization" and "Overview of hysteroscopy".)


Numerous techniques and technologies have been applied to transcervical sterilization, with varying degrees of success. Some methods require visualization of the tubal ostia with hysteroscopy, while others do not. Methods that have been attempted include:

Corrosive agents – nitric acid, phenol [2], quinacrine [3], methyl cyanoacrylate [4]

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information on subscription options, click below on the option that best describes you:

Subscribers log in here

Literature review current through: Nov 2017. | This topic last updated: Oct 24, 2017.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2017 UpToDate, Inc.
  1. http://www.cdc.gov/nchs/data/nhsr/nhsr060.pdf (Accessed on October 09, 2015).
  2. Liu Y, Wu Y, Chen X, et al. A five-year follow-up study on the efficacy and safety of female tubal sterilization by chemical instillation. Reprod Contracept 1999; 10:106.
  3. Zipper J, Kessel E. Quinacrine sterilization: a retrospective. Int J Gynaecol Obstet 2003; 83 Suppl 2:S7.
  4. Shuber J. Transcervical sterilization with use of methyl 2-cyanoacrylate and a newer delivery system (the FEMCEPT device). Am J Obstet Gynecol 1989; 160:887.
  5. Ligt-Veneman NG, Tinga DJ, Kragt H, et al. The efficacy of intratubal silicone in the Ovabloc hysteroscopic method of sterilization. Acta Obstet Gynecol Scand 1999; 78:824.
  6. Cooper JM. Hysteroscopic sterilization. Clin Obstet Gynecol 1992; 35:282.
  7. Quiñones GR, Alvarado AD, Ley EC. Tubal electrocoagulation under hysteroscopic control (three hundred and fifty cases). Am J Obstet Gynecol 1975; 121:1111.
  8. Brumsted JR, Shirk G, Soderling MJ, Reed T. Attempted transcervical occlusion of the fallopian tube with the Nd:YAG laser. Obstet Gynecol 1991; 77:327.
  9. Valle RF, Carignan CS, Wright TC, STOP Prehysterectomy Investigation Group. Tissue response to the STOP microcoil transcervical permanent contraceptive device: results from a prehysterectomy study. Fertil Steril 2001; 76:974.
  10. Casassus B. Contraception implant removed from global market. Lancet 2017; 390:1576.
  11. Vancaillie TG, Anderson TL, Johns DA. A 12-month prospective evaluation of transcervical sterilization using implantable polymer matrices. Obstet Gynecol 2008; 112:1270.
  12. Adiana transcervical sterilization system PMA P070022 draft panel discussion questions, 2007. p.2. www.fda.gov/ohrms/dockets/AC/07/questions/2007-4334%20q1%20FDA%20Draft%20Disc%20quest-Cytyc%20P070022.pdf (Accessed on October 20, 2009).
  13. Mijatovic V, Veersema S, Emanuel MH, et al. Essure hysteroscopic tubal occlusion device for the treatment of hydrosalpinx prior to in vitro fertilization-embryo transfer in patients with a contraindication for laparoscopy. Fertil Steril 2010; 93:1338.
  14. Hitkari JA, Singh SS, Shapiro HM, Leyland N. Essure treatment of hydrosalpinges. Fertil Steril 2007; 88:1663.
  15. Cohen SB, Bouaziz J, Schiff E, et al. In Vitro Fertilization Outcomes After Placement of Essure Microinserts in Patients With Hydrosalpinges Who Previously Failed In Vitro Fertilization Treatment: A Multicenter Study. J Minim Invasive Gynecol 2016; 23:939.
  16. http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/DeviceApprovalsandClearances/PMAApprovals/ucm273626.htm (Accessed on October 12, 2011).
  17. Yunker AC, Ritch JM, Robinson EF, Golish CT. Incidence and risk factors for chronic pelvic pain after hysteroscopic sterilization. J Minim Invasive Gynecol 2015; 22:390.
  18. Brito LG, Cohen SL, Goggins ER, et al. Essure Surgical Removal and Subsequent Symptom Resolution: Case Series and Follow-Up Survey. J Minim Invasive Gynecol 2015; 22:910.
  19. Zurawin RK, Zurawin JL. Adverse events due to suspected nickel hypersensitivity in patients with essure micro-inserts. J Minim Invasive Gynecol 2011; 18:475.
  20. Miño M, Arjona JE, Cordón J, et al. Success rate and patient satisfaction with the Essure sterilisation in an outpatient setting: a prospective study of 857 women. BJOG 2007; 114:763.
  21. Levie MD, Chudnoff SG. Office hysteroscopic sterilization compared with laparoscopic sterilization: a critical cost analysis. J Minim Invasive Gynecol 2005; 12:318.
  22. Syed R, Levy J, Childers ME. Pain associated with hysteroscopic sterilization. JSLS 2007; 11:63.
  23. Duffy S, Marsh F, Rogerson L, et al. Female sterilisation: a cohort controlled comparative study of ESSURE versus laparoscopic sterilisation. BJOG 2005; 112:1522.
  24. Franchini M, Cianferoni L, Lippi G, et al. Tubal sterilization by laparoscopy or hysteroscopy: which is the most cost-effective procedure? Fertil Steril 2009; 91:1499.
  25. Thiel JA, Carson GD. Cost-effectiveness analysis comparing the essure tubal sterilization procedure and laparoscopic tubal sterilization. J Obstet Gynaecol Can 2008; 30:581.
  26. Kraemer DF, Yen PY, Nichols M. An economic comparison of female sterilization of hysteroscopic tubal occlusion with laparoscopic bilateral tubal ligation. Contraception 2009; 80:254.
  27. Cooper JM, Carignan CS, Cher D, et al. Microinsert nonincisional hysteroscopic sterilization. Obstet Gynecol 2003; 102:59.
  28. Gariepy AM, Creinin MD, Smith KJ, Xu X. Probability of pregnancy after sterilization: a comparison of hysteroscopic versus laparoscopic sterilization. Contraception 2014; 90:174.
  29. Mao J, Pfeifer S, Schlegel P, Sedrakyan A. Safety and efficacy of hysteroscopic sterilization compared with laparoscopic sterilization: an observational cohort study. BMJ 2015; 351:h5162.
  30. http://www.hcp.essure-us.com/resources/you/ (Accessed on September 06, 2016).
  31. Agostini A, Crochet P, Petrakian M, et al. Hysteroscopic tubal sterilization (essure) in women with an intrauterine device. J Minim Invasive Gynecol 2008; 15:277.
  32. Mascaro M, Mariño M, Vicens-Vidal M. Feasibility of Essure placement in intrauterine device users. J Minim Invasive Gynecol 2008; 15:485.
  33. Tatalovich JM, Anderson TL. Hysteroscopic sterilization in patients with a Mirena intrauterine device: transition from extended interval to permanent contraception. J Minim Invasive Gynecol 2010; 17:228.
  34. Panel P, Grosdemouge I. Predictive factors of Essure implant placement failure: prospective, multicenter study of 495 patients. Fertil Steril 2010; 93:29.
  35. Scarabin C, Dhainaut C. [The ESTHYME study. Women's satisfaction after hysteroscopic sterilization (Essure micro-insert). A retrospective multicenter survey]. Gynecol Obstet Fertil 2007; 35:1123.
  36. Chudnoff S, Einstein M, Levie M. Paracervical block efficacy in office hysteroscopic sterilization: a randomized controlled trial. Obstet Gynecol 2010; 115:26.
  37. American College of Obstetricians and Gynecologists Committee on Gynecologic Practice. ACOG Committee Opinion No. 458: Hysterosalpingography after tubal sterilization. Obstet Gynecol 2010; 115:1343.
  38. Concomitant use with GEA, US. http://www.essuremd.com/Home/LearningLibrary/Downloads/tabid/281/Default.aspx (Accessed on September 14, 2010).
  39. Valle RF, Valdez J, Wright TC, Kenney M. Concomitant Essure tubal sterilization and Thermachoice endometrial ablation: feasibility and safety. Fertil Steril 2006; 86:152.
  40. Hopkins MR, Creedon DJ, El-Nashar SA, et al. Radiofrequency global endometrial ablation followed by hysteroscopic sterilization. J Minim Invasive Gynecol 2007; 14:494.
  41. Donnadieu AC, Deffieux X, Gervaise A, et al. Essure sterilization associated with endometrial ablation. Int J Gynaecol Obstet 2007; 97:139.
  42. Hopkins MR, Laughlin-Tommaso SK, Wall DJ, et al. Hysterosalpingography After Radiofrequency Endometrial Ablation and Hysteroscopic Sterilization as a Concomitant Procedure. Obstet Gynecol 2015; 126:628.
  43. Carey ET, El-Nashar S, Creedon DJ, et al. Feasibility of hysterosalpingography following a combined radiofrequency global endometrial ablation and hysteroscopic sterilization procedure (abstract). J Minim Invas Gynecol 2009; 16:S38.
  44. Basinski CM, Price P. Essure tubal sterilization combined with subsequent Novasure endometrial ablation: a retrospective analysis. J Minim Invas Gynecol 2009; 16:S62.
  45. Vilos GA, Emanuel MH, Fortin C, et al. Multicentre outpatient thermal balloon endometrial ablation (thermablate). J Minim Invas Gynecol 2009; 16:S69.
  46. http://www.essuremd.com/Portals/essuremd/PDFs/TopDownloads/CC-3032%2028FEB12F%20physician%20customer%20letter.pdf (Accessed on April 10, 2012).
  47. Garza-Leal J, Hernandez L, Castillo NG, et al. Essure transcervical sterilization combined with Novasure endometrial ablation: A perihysterectomy saftey study (abstract). J Minim Invasive Gynecol 2008; 15:44S.
  48. Garza-Leal J, Castillo L, Hernandez I, et al. Concomitant use of Adiana permanent contraception and NovaSure impedance controlled endometrial ablation: a peri-hysterectomy study (abstract). J Minim Invasive Gynecol 2009; 16:S69.
  49. Wishall KM, Price J, Pereira N, et al. Postablation risk factors for pain and subsequent hysterectomy. Obstet Gynecol 2014; 124:904.
  50. Thomassee MS, Curlin H, Yunker A, Anderson TL. Predicting pelvic pain after endometrial ablation: which preoperative patient characteristics are associated? J Minim Invasive Gynecol 2013; 20:642.
  51. Arjona JE, Miño M, Cordón J, et al. Satisfaction and tolerance with office hysteroscopic tubal sterilization. Fertil Steril 2008; 90:1182.
  52. Connor V. Contrast infusion sonography in the post-Essure setting. J Minim Invasive Gynecol 2008; 15:56.
  53. Shavell VI, Abdallah ME, Diamond MP, et al. Post-Essure hysterosalpingography compliance in a clinic population. J Minim Invasive Gynecol 2008; 15:431.
  54. Guiahi M, Goldman KN, Olson CG. Retrospective analysis of hysterosalpingogram confirmatory test follow-up after Essure hysteroscopic sterilization; four-year experience in a community setting (abstract). J Minim Invas Gynecol 2008; 15:78S.
  55. Veersema S, Vleugels MP, Moolenaar LM, et al. Unintended pregnancies after Essure sterilization in the Netherlands. Fertil Steril 2010; 93:35.
  56. Veersema S, Vleugels MP, Timmermans A, Brölmann HA. Follow-up of successful bilateral placement of Essure microinserts with ultrasound. Fertil Steril 2005; 84:1733.
  57. Wittmer MH, Brown DL, Hartman RP, et al. Sonography, CT, and MRI appearance of the Essure microinsert permanent birth control device. AJR Am J Roentgenol 2006; 187:959.
  58. Hurskainen R, Hovi SL, Gissler M, et al. Hysteroscopic tubal sterilization: a systematic review of the Essure system. Fertil Steril 2010; 94:16.
  59. Thoma V, Chua I, Garbin O, et al. Tubal perforation by ESSURE microinsert. J Minim Invasive Gynecol 2006; 13:161.
  60. Chudnoff SG, Nichols JE Jr, Levie M. Hysteroscopic Essure Inserts for Permanent Contraception: Extended Follow-Up Results of a Phase III Multicenter International Study. J Minim Invasive Gynecol 2015; 22:951.
  61. Bradley LD, Price TM, Van Herendael BJ, Cayuela E. Long-term follow-up of hysteroscopic sterilization with the Essure micro-insert (abstract). J Minim Invas Gynecol 2008; 15:14S.
  62. Dhruva SS, Ross JS, Gariepy AM. Revisiting Essure--Toward Safe and Effective Sterilization. N Engl J Med 2015; 373:e17.
  63. http://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/MedicalDevices/MedicalDevicesAdvisoryCommittee/ObstetricsandGynecologyDevices/ucm463457.htm (Accessed on October 09, 2015).
  64. http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/EssurePermanentBirthControl/ucm452254.htm (Accessed on July 17, 2015).
  65. http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/EssurePermanentBirthControl/ucm473946.htm (Accessed on March 22, 2016).
  66. http://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/UCM488020.pdf?source=govdelivery&utm_medium=email&utm_source=govdelivery (Accessed on November 02, 2016).
  67. http://www.hc-sc.gc.ca/dhp-mps/medeff/reviews-examens/essure-eng.php (Accessed on September 06, 2016).
  68. Jansen NE, Vleugels MP, Kluivers KB, Vierhout ME. Bilateral cornual abscess after endometrial ablation following Essure sterilization. J Minim Invasive Gynecol 2007; 14:509.
  69. Solt I, Ioffe Y, Elmore RG, Solnik MJ. Group A streptococcal peritonitis and ruptured tubo-ovarian abscess three years after Essure® insertion: a case report. J Womens Health (Larchmt) 2011; 20:781.
  70. Pakish JB, West L. Actinomyces bacteremia in association with tubo-ovarian abscesses and hysteroscopic sterilization. Obstet Gynecol 2014; 124:451.
  71. Perkins RB, Morgan JR, Awosogba TP, et al. Gynecologic Outcomes After Hysteroscopic and Laparoscopic Sterilization Procedures. Obstet Gynecol 2016; 128:843.
  72. Ouzounelli M, Reaven NL. Essure hysteroscopic sterilization versus interval laparoscopic bilateral tubal ligation: a comparative effectiveness review. J Minim Invasive Gynecol 2015; 22:342.
  73. Al-Safi ZA, Shavell VI, Hobson DT, et al. Analysis of adverse events with Essure hysteroscopic sterilization reported to the Manufacturer and User Facility Device Experience database. J Minim Invasive Gynecol 2013; 20:825.
  74. Langenveld J, Veersema S, Bongers MY, Koks CA. Tubal perforation by Essure: three different clinical presentations. Fertil Steril 2008; 90:2011.e5.
  75. Moses AW, Burgis JT, Bacon JL, Risinger J. Pregnancy after Essure placement: report of two cases. Fertil Steril 2008; 89:724.e9.
  76. Braginsky L, George ST, Locher SR. Management of perforated essure with migration into small and large bowel mesentery. J Minim Invasive Gynecol 2015; 22:504.
  77. Riley K, Beltran F, Stewart D, Harkins G. Bowel perforation after placement of tubal occlusion contraceptive. Obstet Gynecol 2015; 125:860.
  78. Hur HC, Mansuria SM, Chen BA, Lee TT. Laparoscopic management of hysteroscopic essure sterilization complications: report of 3 cases. J Minim Invasive Gynecol 2008; 15:362.
  79. Lane A, Tyson A, Thurston E. Providing Re-Essure-ance to the Nickel-Allergic Patient Considering Hysteroscopic Sterilization. J Minim Invasive Gynecol 2016; 23:126.
  80. Al-Safi Z, Shavell VI, Katz LE, Berman JM. Nickel hypersensitivity associated with an intratubal microinsert system. Obstet Gynecol 2011; 117:461.
  81. Bibas N, Lassere J, Paul C, et al. Nickel-induced systemic contact dermatitis and intratubal implants: the baboon syndrome revisited. Dermatitis 2013; 24:35.
  82. Albright CM, Frishman GN, Bhagavath B. Surgical aspects of removal of Essure microinsert. Contraception 2013; 88:334.
  83. Lannon BM, Lee SY. Techniques for removal of the Essure hysteroscopic tubal occlusion device. Fertil Steril 2007; 88:497.e13.
  84. Monteith CW, Berger GS, Zerden ML. Pregnancy success after hysteroscopic sterilization reversal. Obstet Gynecol 2014; 124:1183.
  85. Howard DL, Christenson PJ, Strickland JL. Use of intraoperative fluoroscopy during laparotomy to identify fragments of retained Essure microinserts: case report. J Minim Invasive Gynecol 2012; 19:667.
  86. la Chapelle CF, Veersema S, Brölmann HA, Jansen FW. Effectiveness and feasibility of hysteroscopic sterilization techniques: a systematic review and meta-analysis. Fertil Steril 2015; 103:1516.
  87. Levy B, Levie MD, Childers ME. A summary of reported pregnancies after hysteroscopic sterilization. J Minim Invasive Gynecol 2007; 14:271.
  88. Cleary TP, Tepper NK, Cwiak C, et al. Pregnancies after hysteroscopic sterilization: a systematic review. Contraception 2013; 87:539.
  89. Hitzerd E, Schreuder HW, Vleugels MP, Veersema S. Twelve-year retrospective review of unintended pregnancies after Essure sterilization in the Netherlands. Fertil Steril 2016; 105:932.
  90. Rattray D, Thiel P, Suchet I, Thiel J. Confirmation Testing of Essure Microinserts in Unintended Pregnancies Using a 10-Year Retrospective Database. J Minim Invasive Gynecol 2016; 23:944.
  91. Kerin JF, Cattanach S. Successful pregnancy outcome with the use of in vitro fertilization after Essure hysteroscopic sterilization. Fertil Steril 2007; 87:1212.e1.